Right Way Medical Revolutionizes Early Infection & Inflammatory Detection
Columbus, OH (November 13, 2024) – Right Way Medical is proud to announce the launch of its first wearable device, TempShield, designed to help clinicians and patients detect infections and inflammation earlier than ever before. This innovative technology provides a critical advantage in identifying potential health concerns before they become acute.
TempShield can be the difference between an antibiotic prescription and a hospitalization for immunocompromised patients. It’s like a ‘check engine light’ for the body, alerting patients and their clinicians early if an infection is developing. By monitoring temperature trends early on, patients, caregivers, and clinicians can take proactive steps to manage care, improving treatment outcomes and providing peace of mind.
TempShield, developed by Aion Biosystems, features the longest-lasting wearable body temperature monitor on the market, with an impressive 90-day battery life. At only 42mm in size, TempShield is discreet, comfortable, and designed to encourage high patient compliance.
Additionally, TempShield is reimbursable for 99% of patients aged 5 and older, with coverage through Medicare and most private insurance plans. For many patients, there is little to no out-of-pocket cost.
“The TempShield is to immunocompromised patients what a blood glucose monitor is to diabetics,”
said Dr. Tallat Mahmood, Director of Medical Oncology, Roswell Park Cancer Center’s Ellis Medicine.
TempShield allows patients and caregivers to easily download the accompanying app to monitor temperature data in real-time. This device offers a significant upgrade over traditional fever detection methods, which typically rely on patients taking their own oral temperature—a practice that many people neglect when they feel healthy. TempShield alerts users developing a fever days before symptoms appear, often identifying issues 2-3 days before they become clinically significant.
“This early detection is crucial. We are identifying fevers and potential infections before patients even realize there’s an issue,”
said Samara Barend, CEO of Aion Biosystems.
TempShield is especially beneficial for immunocompromised patients or those managing chronic inflammation, as body temperature can serve as an early warning signal for both infections and inflammation.
By monitoring temperature trends early on, patients, caregivers, and clinicians can take proactive steps to manage care, improving treatment outcomes and providing peace of mind.
The product is available for immediate shipment to all 50 states, marking the start of this exciting partnership between Right Way Medical and Aion Biosystems.
About Right Way Medical:
Right Way Medical is a national concierge of medical products for alternate-site care, long-term care, and specialty pharmacy providers. With over a decade of experience, we set the standard for transparency and responsiveness in the healthcare market, offering infusion devices, disposables, biomedical services, and asset tracking software, Right Track.
About AION Biosystems:
AION Biosystems is a medical technology company dedicated to identifying infection before it becomes life threatening. The company’s TempShield device received FDA 510k clearance in 2023 and has demonstrated compelling clinical results in oncology.
Elevate your standard of care in two major areas.
Standard of Care | Oncology Standard of Care | Sepsis